Pfizer offers SA discounted vaccine, but it’s still too much
At $10 a dose, half what it costs in the US, the presidency says the cost is prohibitive as unions pressure the ANC over vaccines
Pfizer and BioNTech have offered to supply SA with their Covid-19 vaccine at a discounted $10 a dose, yet the president’s office still describes the cost as prohibitive, according to a person familiar with the talks.
The price was worked out according to SA’s status as a middle-income nation and is about half what the drugmakers are charging in the US, the person said, asking not to be identified as the information hasn’t been made public.
That the companies are running a vaccine trial in SA was also taken into consideration, the person said.
A spokesperson for the department of health said the ministry can’t comment on the pricing as a deal is yet to be concluded. Representatives for Pfizer and BioNTech in Europe didn’t immediately respond to a request for comment.
The government is coming under mounting pressure from its union allies, opposition parties and medical professionals over its failure to secure any bilateral vaccine-supply agreements with pharmaceutical companies. While at least 29 countries have already begun inoculating their populations, SA only expects to start getting shots for about 10% of its population in the second quarter. That deal has been arranged through the Covax initiative, which is designed to ensure poorer countries can secure access.
The country has had 1.1-million confirmed cases of Covid-19 and is approaching 30,000 deaths, the most of any African nation.
In a statement sent to Bloomberg News on Sunday, the presidency said Pfizer is one of at least three companies the government is in negotiations with for the supply of shots. It also said Pfizer has offered 50-million doses for health workers across Africa that could arrive between March and the end of 2021.
“Factors that will be taken into account include the suitability for the SA context,” the presidency said, noting that the Pfizer vaccine requires ultra-cold storage. “The cost is also prohibitive.”
Tyrone Seale, acting spokesperson for President Cyril Ramaphosa, declined to comment further.
Would you like to comment on this article or view other readers' comments?
Register (it’s quick and free) or sign in now.
Please read our Comment Policy before commenting.